Fielmann AG (ADR)
General ticker "FLMNY" information:
- Sector: Health Care
- Industry: Medical - Instruments & Supplies
- Capitalization: $4.8B (TTM average)
Fielmann AG (ADR) does not follow the US Stock Market performance with the rate: -37.9%.
Estimated limits based on current volatility of 0.0%: low 9.94$, high 9.94$
Factors to consider:
- Company pays dividends (annually): last record date 2025-07-14, amount 0.27$ (Y2.72%)
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [9.91$, 15.39$]
- 2026-12-31 to 2027-12-31 estimated range: [11.07$, 16.90$]
Financial Metrics affecting the FLMNY estimates:
- Positive: with PPE of 11.1 at the end of fiscal year the price was low
- Positive: 6.59 < Operating cash flow per share per price, % of 10.92
- Positive: 7.54 < Operating profit margin, % of 13.29
- Positive: Return on assets ratio (scaled to [-100,100]) of 6.90 > 6.06
- Positive: Inventory ratio change, % of -1.60 <= -0.75
- Positive: 19.24 < Shareholder equity ratio, % of 36.84 <= 42.59
Short-term FLMNY quotes
Long-term FLMNY plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | €1,969.08MM | €2,264.12MM | €2,339.22MM |
| Operating Expenses | €1,682.53MM | €1,922.44MM | €2,028.45MM |
| Operating Income | €286.55MM | €341.68MM | €310.77MM |
| Non-Operating Income | €-92.83MM | €-122.83MM | €-30.60MM |
| Interest Expense | €23.75MM | €41.87MM | €41.97MM |
| Income(Loss) | €193.72MM | €218.85MM | €280.17MM |
| Taxes | €63.08MM | €64.64MM | €82.79MM |
| Net Income(Loss)* | €127.64MM | €152.11MM | €195.69MM |
| Stockholders Equity | €792.02MM | €899.13MM | €981.36MM |
| Inventory | €224.74MM | €259.32MM | €222.12MM |
| Assets | €1,986.55MM | €2,368.95MM | €2,663.81MM |
| Operating Cash Flow | €282.79MM | €410.09MM | €446.40MM |
| Capital expenditure | €86.79MM | €82.69MM | €108.27MM |
| Investing Cash Flow | €-143.25MM | €-331.17MM | €-111.93MM |
| Financing Cash Flow | €-132.00MM | €-44.27MM | €-214.80MM |
| Earnings Per Share** | €0.30 | €0.36 | €0.47 |
| Ordinary share to ADR | 1.00x | 1.00x | 1.00x |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.